Rituximab in Relapsing and Progressive Forms of Multiple Sclerosis: A Systematic Review

Overview of attention for article published in PLOS ONE, July 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

So far, Altmetric has seen 28 patents that reference this research output.

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity, including 24 additional patents.